Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms
P Huang, LY Zhang, YY Tan, SD Chen - Translational Neurodegeneration, 2023 - Springer
The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with
neurodegenerative diseases and the specific neurological manifestations of COVID-19 have …
neurodegenerative diseases and the specific neurological manifestations of COVID-19 have …
Post-COVID-19 human memory impairment: A PRISMA-based systematic review of evidence from brain imaging studies
D Shan, S Li, R Xu, G Nie, Y Xie, J Han… - Frontiers in aging …, 2022 - frontiersin.org
Many people with coronavirus disease 2019 (COVID-19) report varying degrees of memory
impairment. Neuroimaging techniques such as MRI and PET have been utilized to shed light …
impairment. Neuroimaging techniques such as MRI and PET have been utilized to shed light …
Morphological, cellular, and molecular basis of brain infection in COVID-19 patients
Although increasing evidence confirms neuropsychiatric manifestations associated mainly
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …
Neurological and Psychiatric Manifestations of Long COVID-19 and Their [18F]FDG PET Findings: A Review
R Hameed, AR Bahadur, SB Singh, J Sher, M Todua… - Diagnostics, 2023 - mdpi.com
For more than two years, lingering sequalae of COVID-19 have been extensively
investigated. Approximately 10% of individuals infected by COVID-19 have been found to …
investigated. Approximately 10% of individuals infected by COVID-19 have been found to …
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
C Zhu, S Pang, J Liu, Q Duan - Drugs, 2024 - Springer
The COVID-19 pandemic has resulted in over 772 million confirmed cases, including nearly
7 million deaths, according to the World Health Organization (WHO). Leveraging rapid …
7 million deaths, according to the World Health Organization (WHO). Leveraging rapid …
Persistent 18F-FDG brain PET fronto-temporal hypometabolism and cognitive symptoms two years after SARS-CoV-2 infection: A case report
At least 10% of patients experience persistent symptoms after SARS-CoV-2 infection, a
condition referred to as post-acute COVID-19, post-acute sequelae of SARS-CoV-2 infection …
condition referred to as post-acute COVID-19, post-acute sequelae of SARS-CoV-2 infection …
[PDF][PDF] Neurological and Psychiatric Manifestations of Long COVID-19 and Their [18F] FDG PET Findings: A Review. Diagnostics 2023, 13, 2353
R Hameed, AR Bahadur, SB Singh, J Sher, M Todua… - 2023 - pdfs.semanticscholar.org
For more than two years, lingering sequalae of COVID-19 have been extensively
investigated. Approximately 10% of individuals infected by COVID-19 have been found to …
investigated. Approximately 10% of individuals infected by COVID-19 have been found to …